[Categories and characteristics of BPH drug evaluation models: a comparative study]

Area of Science:

• Urology and Pharmacology
• Drug Discovery and Development

Context:

• Benign prostatic hyperplasia (BPH) is a prevalent condition affecting men over 50 globally.
• The precise etiology of BPH remains largely undetermined.
• Developing effective therapeutic strategies for BPH is a significant clinical challenge.

Purpose:

• To comprehensively analyze existing drug evaluation models for benign prostatic hyperplasia (BPH).
• To characterize the features and applicability of various BPH models.
• To provide a theoretical foundation for the advancement of BPH therapeutics.

Summary:

• This article reviews diverse BPH models used for drug screening and pathogenesis research.
• It details the categories, characteristics, and application value of each model.
• The analysis aims to guide the selection of appropriate models for preclinical drug evaluation.

Impact:

• Facilitates informed selection of BPH models for drug development.
• Supports the screening of novel and effective pharmaceutical agents for BPH.
• Contributes to a better understanding of BPH pathogenesis through model system analysis.